Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma
Open Access
- 1 November 2020
- journal article
- research article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 13 (5), 1
- https://doi.org/10.3892/mco.2020.2134
Abstract
Amplification and overexpression of the human epidermal growth factor receptor-2 (HER-2) gene accelerates cell division and proliferation, and promotes tumor growth and metastasis in various malignant tumors. However, there are few reports on its influence and mechanism in esophageal cancer. The aim of the present study was to investigate the gene amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma (ESCC). HER-2 gene amplification was detected in 70 esophageal cancer tissues using fluorescence in situ hybridization. The association between the HER-2 gene amplification and the clinicopathological characteristics of patients with esophageal cancer was also analyzed. The amplification rate of the HER-2 gene in patients with esophageal cancer was 54.2% (38/70). The results also revealed a positive association between the amplification rate of the HER-2 gene in esophageal squamous cell carcinomas and the level of tissue differentiation, increasing gradually and significantly among the highly, moderately and poorly differentiated tissues (P<0.05). The amplification rate of the HER-2 gene in patients with lymph node metastasis was higher than those without (P0.05). In conclusion, the amplification rate of the HER-2 gene in patients with Kazakh ESCC was high. There was an association with various prognostic factors, including cancer differentiation and lymph node metastasis. HER-2 gene expression levels may be considered as an indicator of poor prognosis in patients with ESCC in the clinical setting, and this may provide a basis of treatment for individualized targeted therapies.Keywords
This publication has 23 references indexed in Scilit:
- HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinomaOncology Letters, 2013
- Relationships Between Immunophenotype, Ki-67 Index, Microvascular Density, Ep-CAM/P-cadherin, and MMP-2 Expression in Early-stage Invasive Ductal Breast CancerApplied Immunohistochemistry & Molecular Morphology, 2012
- Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of JapanBreast Cancer, 2011
- Clinicopathologic significance of HER-2/neu protein expression and gene amplification in gastric carcinomaWorld Journal of Gastroenterology, 2011
- Esophageal cancer—the five year survivorsJournal of Surgical Oncology, 2010
- Emerging Targeted Therapies for Breast CancerJournal of Clinical Oncology, 2010
- Histology of Metaplasia and Dysplasia in Barrett's EsophagusSurgical Oncology Clinics of North America, 2009
- Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistryBMC Cancer, 2009
- A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagusHuman Pathology, 2008
- Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagusLaboratory Investigation, 2007